Invert was founded by Martin T. Permin, Holger Thorup in 2021.

Who are Invert's investors?

Invert's investors include ACME Capital, Cathexis Ventures, Giant Ventures Global Llp, Positive Sum Capital, Y Combinator, TechNexus Venture Collaborative.

How much funding has Invert raised?

Invert has disclosed $20.1M raised across 1 round.

Where is Invert headquartered?

Invert is headquartered in San Francisco, US.

Invert

YC W22

San Francisco, US · Founded 2021 · Delaware corporation · 25 employees · Hiring · 6 known investors

Find your way into Invert

Paths you didn't know you had: your email and LinkedIn already hold routes to the Invert team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Invert provides infrastructure and intelligence software that connects bioprocess equipment and data sources for pharmaceutical and biologics companies, enabling faster process development and manufacturing through integrated data platforms and digital twin capabilities.

Also known as Invert Bio

AI & Machine Learning Biotech Data & Infrastructure Enterprise Software Healthtech Cellular Agriculture Machine Learning Synthetic BiologyUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (W22)

Invert was founded in 2021 by Martin T. Permin and Holger Thorup.

Martin T. Permin Co-Founder/ceoMartin Permin previously worked at Airbnb and Hive (a Y Combinator-backed company). He has a background in biology and data.

Holger Thorup Co-Founder & CTOHolger Thorup was VP of Engineering at ZeroNorth and co-founder and CTO at Pelion. He has background in management consulting.

Sam CatesNamed on SEC filing

Gareth MacLeod Head of EngineeringFounder/CEO at Tinker

Jonas NeubertIntegrations Engineering

Suhas GuruprasadHead of AI

Benjamin CostiganChief of Staff

Mads Ingwar

Rob Lambert

Andy ElmsleyHead of Engineeringformer

Michael McCutchenSolutions Engineerformer

Board

Christian Tang-Jespersen Board MemberPartner at ACME Capital

Investors · 6

ACME Capitallisted by ACME CapitalSan Francisco

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Cathexis Ventureslisted by Cathexis VenturesHouston · $250K – $1Mvia Mark Friday · inferred

How we know: Cathexis Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Giant Ventures Global Llplisted by Giant Ventures Global LlpLondon · $10M – $20M

How we know: Giant Ventures Global Llp's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Positive Sum Capitallisted by Positive Sum CapitalGreenwich · $5M

How we know: Positive Sum Capital's portfolio page · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

TechNexus Venture CollaborativereportedChicago

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$20.1M disclosed across 1 round · 2024

▶$20.1MraisedJul 2024 · 16 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Martin Tromp PerminExecutive Officer, Director
Holger Hjorth ThorupDirector
Christian Tang-JespersenDirector
Sam CatesDirector

Offering amount: $21.7M
Amount sold: $20.1M
First sale: Jun 2024
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

4 people who came through Invert went on to found or lead other companies.

Christian Tang-JespersenDirectorFounded Heptagon Advanced Micro-Optics Gareth MacLeodChief of Technical StaffFounded Tinker Vivek RajaSoftware EngineerFounded Terminal Use Victoria R. ZellmerDirector of Strategic AccountsFounded Estrigenix Therapeutics

Related companies · 9

Brown FoodsUnreal Milk produces lab-grown whole cow milk using cellular agriculture technology. The company targets consumers seeking sustainable dairy alternatives.

Recursion PharmaceuticalsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.

CB TherapeuticsCB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods. The company serves pharmaceutical and specialty chemical manufacturers.

Culture BiosciencesCulture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.

ShiruShiru uses AI and material science to discover natural proteins and ingredients for use in food, personal care, agriculture, and advanced materials, reducing traditional development timelines from 5-15 years to 1-2 years.

SurfSurf Bio is a preclinical biopharmaceutical company developing its SnapShot technology, which uses a proprietary polymer to create ultra-high-concentration antibody and biologic formulations (600+ mg/mL, doses over 1,000 mg) for delivery via a standard autoinjector. The technology enables at-home subcutaneous self-injection of monoclonal antibodies and biologics as an alternative to in-clinic IV infusion, and is offered to pharmaceutical API manufacturers through partnerships.

RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.

Converge BioConverge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies. The company provides AI solutions for target discovery, antibody design, protein manufacturing optimization, and biomarker discovery.

Inductive BioInductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.

Companies working in the same space as Invert.

Legal entities · 1

corporate structure

Invert, Inc.

Frequently asked questions

What does Invert do?: Invert provides infrastructure and intelligence software that connects bioprocess equipment and data sources for pharmaceutical and biologics companies, enabling faster process development and manufacturing through integrated data platforms and digital twin capabilities.
Who founded Invert?: Invert was founded by Martin T. Permin, Holger Thorup in 2021.
Who are Invert's investors?: Invert's investors include ACME Capital, Cathexis Ventures, Giant Ventures Global Llp, Positive Sum Capital, Y Combinator, TechNexus Venture Collaborative.
How much funding has Invert raised?: Invert has disclosed $20.1M raised across 1 round.
Where is Invert headquartered?: Invert is headquartered in San Francisco, US.